好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2023 Annual Meeting | C209 - Headache in Special Populations

Thursday 04/27/23
03:30 PM - 05:30 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Larry "LC" Charleston IV, MD, MSc, FAHS, FANA
Headache
Participants should understand the definition of special populations in headache medicine; key epidemiology of special populations in headache medicine; and be able to define intersectionality and articulate its importance in the care of special populations.
2.00 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic, Audience Participation, Other
Event Timeline
03:30 PM - 03:45 PM EST Speaker Introduction to Special Populations in Headache Medicine
Larry "LC" Charleston IV, MD, MSc, FAHS, FANA
03:45 PM - 04:25 PM EST Speaker Case Review of Headache Management in Selected Special Populations
Larry "LC" Charleston IV, MD, MSc, FAHS, FANA, Michael Stitzer, MD, Angeliki Vgontzas, MD, Juliana VanderPluym, MD
03:45 PM - 04:25 PM EST Speaker Case Review of Headache Management in Selected Special Populations
Michael Stitzer, MD
04:25 PM - 04:35 PM EST Discussion Questions and Answers
Larry "LC" Charleston IV, MD, MSc, FAHS, FANA
04:35 PM - 04:40 PM EST Speaker Introduction to Intersectionality in Health
Larry "LC" Charleston IV, MD, MSc, FAHS, FANA
04:40 PM - 05:20 PM EST Speaker Intersectionality in Headache Medicine: A Case-based Panel and Audience-participatory Roundtable Discussion
Larry "LC" Charleston IV, MD, MSc, FAHS, FANA, Michael Stitzer, MD, Angeliki Vgontzas, MD, Juliana VanderPluym, MD
05:20 PM - 05:30 PM EST Discussion Questions, Answers, and Closing Remarks
Larry "LC" Charleston IV, MD, MSc, FAHS, FANA
Faculty Disclosures
Larry "LC" Charleston IV, MD, MSc, FAHS, FANA Dr. Charleston has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LinPharma. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haleon. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Charleston has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Charleston has stock in Mi-Helper Inc.. Dr. Charleston has a non-compensated relationship as a Associate Editor with Headache Journal: The Journal of Head and Face Pain that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Board Member with Clinical Neurological Society of America that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Chair, EDI Advisory Committee (Non-voting Board Member) with American Headache Society that is relevant to AAN interests or activities.
Michael Stitzer, MD Dr. Stitzer has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生.
Angeliki Vgontzas, MD Dr. Vgontzas has nothing to disclose.
Juliana VanderPluym, MD Dr. VanderPluym has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology and Neuroscience Reports. The institution of Dr. VanderPluym has received research support from Amgen.